Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial
Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial. // Drug and Alcohol Dependence Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2772724626000806?dgcid=rss_sd_all
Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial. Drug and Alcohol Dependence Reports. https://www.sciencedirect.com/science/article/pii/S2772724626000806?dgcid=rss_sd_all
“Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial.” Drug and Alcohol Dependence Reports.
@article{article43365,
title = {Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial},
journal = {Drug and Alcohol Dependence Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2772724626000806?dgcid=rss_sd_all}
}